Business Context and Reporting Period
This Form 8-K was filed by Second Sight Medical Products, Inc. (trading symbol: EYES) on December 10, 2020, reporting events occurring on December 8, 2020. The company is an emerging growth company incorporated in California. Note: The request metadata references "Vivani Medical, Inc.," but the filing text explicitly identifies the registrant as Second Sight Medical Products, Inc.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, or overall liquidity metrics. It specifically discloses a new debt obligation:
- Total Borrowings: $2.2 million
- Lenders: $1.0 million from Gregg Williams (Chairman of the Board) and $1.2 million from two unaffiliated shareholders.
- Interest Rate: 12% per annum.
- Maturity Date: December 31, 2021.
- Security: Unsecured promissory notes.
Material Changes
The primary material change is the entry into a Material Definitive Agreement to secure short-term financing. The company has increased its debt load by $2.2 million to fund operations or other corporate purposes, with interest accruing immediately upon receipt of funds.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future performance, or specific risk factors beyond the terms of the loan. The agreement includes a prepayment clause allowing the company to repay the notes in whole or in part at any time without penalty or prior notice.
Investor Verification Checklist
- Verify the company's current cash position and ability to service the $2.2 million debt plus 12% interest by the December 31, 2021 maturity date.
- Confirm the identity of the "two unaffiliated shareholders" providing the $1.2 million loan to assess potential related-party transaction risks.
- Review the full text of Exhibit 10.1 (Form of Promissory Note) for any covenants or default provisions not summarized in the 8-K.
- Check subsequent filings to determine if the company has refinanced this debt or if it was repaid prior to maturity.